Harry Sloan - Dec 11, 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Stock symbol
DNA
Transactions as of
Dec 11, 2024
Transactions value $
$0
Form type
4
Date filed
12/13/2024, 05:33 PM
Previous filing
Dec 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Other +236K +950.07% 261K Dec 11, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received in a distribution from Eagle Equity Partners III LLC to its members.
F2 This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.